UY36344A - COMPOSITIONS AND METHODS USED TO INCREASE THE IMMUNE RESPONSE AND IN CANCER THERAPY - Google Patents
COMPOSITIONS AND METHODS USED TO INCREASE THE IMMUNE RESPONSE AND IN CANCER THERAPYInfo
- Publication number
- UY36344A UY36344A UY0001036344A UY36344A UY36344A UY 36344 A UY36344 A UY 36344A UY 0001036344 A UY0001036344 A UY 0001036344A UY 36344 A UY36344 A UY 36344A UY 36344 A UY36344 A UY 36344A
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions
- immune response
- increase
- cancer therapy
- methods used
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona composiciones de anticuerpos, incluyendo, por ejemplo,anticuerpos, anticuerpos diseñados y fragmentos de anticuerpos que se unen a un miembro de la superfamilia del receptor del factor de necrosis tumoral (es decir, miembro 18). Las composiciones proporcionadas son útiles en la mejora de las respuestas de células T CD4 y CD8, y en el tratamiento, mejora y prevención de enfermedades que pueden ser contrarrestadas con una respuesta inmune aumentada, por ejemplo, cánceres. También se proporciona en la invención polinucleótidos y vectores que codifican dichas moléculas y células hospederas que albergan los polinucleótidos o vectores; así como composiciones farmacéuticas que comprenden tales moléculas, métodos y el uso de los mismos.The present invention provides antibody compositions, including, for example, antibodies, designed antibodies and antibody fragments that bind to a member of the tumor necrosis factor receptor superfamily (i.e., member 18). The compositions provided are useful in improving the responses of CD4 and CD8 T cells, and in the treatment, improvement and prevention of diseases that can be counteracted with an increased immune response, for example, cancers. Also provided in the invention are polynucleotides and vectors encoding said molecules and host cells that house the polynucleotides or vectors; as well as pharmaceutical compositions comprising such molecules, methods and the use thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462061644P | 2014-10-08 | 2014-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY36344A true UY36344A (en) | 2016-06-01 |
Family
ID=56192084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001036344A UY36344A (en) | 2014-10-08 | 2015-10-06 | COMPOSITIONS AND METHODS USED TO INCREASE THE IMMUNE RESPONSE AND IN CANCER THERAPY |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR105945A1 (en) |
UY (1) | UY36344A (en) |
-
2015
- 2015-10-06 UY UY0001036344A patent/UY36344A/en not_active Application Discontinuation
- 2015-10-08 AR ARP150103257A patent/AR105945A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR105945A1 (en) | 2017-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20170138A (en) | COMPOSITIONS AND METHODS USED TO INCREASE THE IMMUNE RESPONSE AND IN CANCER THERAPY | |
CL2018003153A1 (en) | Antibody molecules for the treatment of cancer. | |
CY1125260T1 (en) | TIGIT COMMITMENT FACTORS AND THEIR USES | |
CL2018001512A1 (en) | Humanized anti-CD73 antibodies. | |
CL2019000146A1 (en) | Anti-gprc5d antibodies, biospecific antigen binding molecules that bind gprc5d and cd3, and related uses. | |
EA201992131A1 (en) | HIGH-AFFINE SPECIFIC TO MAGE-A1 TCR AND THEIR APPLICATION | |
AR115389A1 (en) | CD73 ANTAGONIST ANTIBODY | |
SV2018005634A (en) | ANTI-BCMA ANTIBODIES, BIO-SPECIFIC ANTIGEN MOLECULES THAT JOIN BCMA AND CD3, AND USES OF THESE | |
BR112016030740A2 (en) | bispecific heterodimeric bodies and their uses | |
CL2018000422A1 (en) | Bispecific monovalent diabodies that are capable of binding to b7-h3 and cd3, and uses thereof | |
PH12016502267A1 (en) | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof | |
BR112019011450A2 (en) | modified natural killer cells and their use | |
ECSP18041733A (en) | COMPOSITIONS OF ANTIBODY GRAFTED WITH CYTOKINE AND METHODS FOR ITS USE IN IMMUNOREGULATION | |
EA201691631A1 (en) | CANCER IMMUNOTHERAPY WITH THE USE OF COMBINATION OF LOCAL AND SYSTEMIC IMMUNE STIMULATION | |
BR112016030462A2 (en) | binding molecules, one or more isolated polynucleotides, one or more vectors, host cell, method of producing a binding molecule, pharmaceutical composition, use of the binding molecule, method of treating disease and inducing target cell lysis | |
ECSP18096095A (en) | ALPHA-SINUCLEIN ANTIBODIES AND USES OF THEM | |
EP3964527A3 (en) | Combination therapy for cancer | |
UY35399A (en) | CONJUGATES OF DRUGS WITH ANTIBODIES | |
CL2016002004A1 (en) | Anti-jagged1 antibodies and methods of use | |
EA201690868A1 (en) | PERSONALIZED IMMUNOTHERAPY OF SEVERAL TYPES OF NEURAL TUMORS AND TUMORS OF THE BRAIN | |
CL2018001722A1 (en) | New anti-mfi2 antibodies and methods of use (divisional application 201700506) | |
EA201790334A1 (en) | Conjugates Anti-CDH6 Antibodies With Medicinal Products | |
UY36344A (en) | COMPOSITIONS AND METHODS USED TO INCREASE THE IMMUNE RESPONSE AND IN CANCER THERAPY | |
BR112016001775A2 (en) | COMPOSITION, METHODS OF TREATMENT OF A HUMAN WHO HAS BEEN DIAGNOSED WITH CANCER, OF CANCER PREVENTION IN A HUMAN AT HIGH RISK OF RECEIVING CANCER, AND OF PRODUCING A COMPOSITION OF AN ISOLATED HUMAN ANTI-TUMOR NK CELL POPULATION AND A DENDRITIC CELL POPULATION HUMAN ANTITUMOR ISOLATED, HUMAN NK AND DENDRITIC CELLS ISOLATED, E, KIT | |
AR119964A2 (en) | ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20220712 |